Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer
暂无分享,去创建一个
J. Muratet | F. Denis | A. Septans | Y. Pointreau | S. Krhili | S. Roche | S. Yossi
[1] J. Choi,et al. Clinical Investigation : Gynecologic Cancer Prognostic Significance of Tumor Response as Assessed by Sequential 18 F-Fluorodeoxyglucose-Positron Emission Tomography / Computed Tomography During Concurrent Chemoradiation Therapy for Cervical Cancer , 2013 .
[2] P. Grigsby,et al. Changes in cervical cancer FDG uptake during chemoradiation and association with response. , 2013, International journal of radiation oncology, biology, physics.
[3] B. C. Penney,et al. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. , 2013, Academic radiology.
[4] P. Grigsby,et al. FDG-PET-based prognostic nomograms for locally advanced cervical cancer. , 2012, Gynecologic oncology.
[5] Hyun Woo Kwon,et al. Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis in Patients with Epithelial Ovarian Cancer , 2012, Annals of Surgical Oncology.
[6] R. Crevoisier,et al. Metabolic Monitoring by 18F-FDG PET during Radio-chemotherapy for Locally Advanced Cervical Cancer: Predicting Outcome , 2011 .
[7] H. Chung,et al. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. , 2011, Gynecologic oncology.
[8] J. Thigpen,et al. Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix , 2011 .
[9] H. Min,et al. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[10] S. Pecorelli. Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium” , 2010 .
[11] Brit B. Turnbull,et al. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. , 2008, International journal of radiation oncology, biology, physics.
[12] P. Grigsby,et al. 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer. , 2008, International journal of radiation oncology, biology, physics.
[13] Jun Duan,et al. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage. , 2008, International journal of radiation oncology, biology, physics.
[14] P. Grigsby,et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. , 2007, JAMA.
[15] G. Scambia,et al. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. , 2007, Gynecologic oncology.
[16] Quynh-Thu Le,et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[17] P. Grigsby,et al. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. , 2006, International journal of radiation oncology, biology, physics.
[18] M. Aglietta,et al. Positron-emission tomography in cancer therapy. , 2006, The New England journal of medicine.
[19] P. Grigsby,et al. Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix. , 2005, International journal of radiation oncology, biology, physics.
[20] J. Tierney,et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. , 2005, The Cochrane database of systematic reviews.
[21] David Binns,et al. Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation. , 2004, International journal of radiation oncology, biology, physics.
[22] Chun-Chieh Wang,et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. , 2004, International journal of radiation oncology, biology, physics.
[23] Imran Zoberi,et al. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Mitchell Morris,et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] M. Schwaiger,et al. Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] P. Grigsby,et al. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. , 2003, International journal of radiation oncology, biology, physics.
[27] M. Johnston,et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).
[28] John L. Humm,et al. Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.